1 Lakh
Investment Grown to₹ 10000
Monthly SIP Grown toSuitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1-Day | 1-W | 1-M | 3-M | 6-M | 1-Y | 3-Y | 5-Y | 7-Y | 10-Y | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 10.85 | 0.92 | -0.48 | -1.90 | -7.33 | 0.16 | 15.68 | -- | -- | -- | -- |
| S&P BSE Healthcare TRI | 17.57 | 0.86 | 0.09 | 0.45 | -5.08 | 2.92 | 23.53 | -- | -- | -- | -- |
| Equity: Sectoral-Pharma | 15.58 | 0.82 | -0.05 | -0.70 | -5.36 | 2.60 | 21.40 | -- | -- | -- | -- |
| Rank within category | 9 | 3 | 13 | 11 | 12 | 9 | 9 | -- | -- | -- | -- |
| Number of funds in category | 9 | 14 | 14 | 13 | 12 | 11 | 9 | 6 | 4 | 3 | 3 |
As on 02-Dec-2021
| Fund name | Rating | Launch Date | 1-Year Return | 3-Year Return | 5-Year Return | Expense Ratio | Assets (Cr) |
|---|---|---|---|---|---|---|---|
| IDBI Healthcare Fund - Regular Plan | Feb-19 | 15.68 | -- | -- | 2.51% | 75 | |
| Nippon India Pharma Fund | Jun-04 | 25.11 | 25.34 | 16.24 | 1.89% | 5,210 | |
| ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | Invest Now | Jul-18 | 19.55 | 25.75 | -- | 1.99% | 3,045 | |
| SBI Healthcare Opportunities Fund | Invest Online | Jul-99 | 19.08 | 22.10 | 10.23 | 2.11% | 1,872 | |
| Mirae Asset Healthcare Fund - Regular Plan | Invest Online | Jul-18 | 28.81 | 30.24 | -- | 2.08% | 1,798 |
| Best Performance | Worst Performance | |||
|---|---|---|---|---|
| Return (%) | Period | Return (%) | Period | |
| Week | 21.25 | 01-Apr-2020 - 09-Apr-2020 | -10.89 | 05-Mar-2020 - 12-Mar-2020 |
| Month | 34.24 | 23-Mar-2020 - 22-Apr-2020 | -19.39 | 20-Feb-2020 - 23-Mar-2020 |
| Quarter | 43.01 | 23-Mar-2020 - 22-Jun-2020 | -12.18 | 23-Dec-2019 - 23-Mar-2020 |
| Year | 72.37 | 23-Mar-2020 - 23-Mar-2021 | -7.88 | 22-Mar-2019 - 23-Mar-2020 |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| Fund | -- | -- | -- | -- | -- | -- |
| S&P BSE Healthcare TRI* | 22.17 | 21.63 | 0.85 | 1.79 | -- | -- |
| Equity: Sectoral-Pharma* | 24.89 | 19.80 | 1.07 | 2.36 | 0.90 | 4.63 |
| Rank within category | -- | -- | -- | -- | -- | -- |
| Number of funds in category | -- | -- | -- | -- | -- | -- |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on
* As on 30-Nov-2021
Please wait...
| Number of Stocks | 29 |
| Top 10 Stocks (%) | 66.52 |
| Top 5 Stocks (%) | 48.21 |
| Top 3 Sectors (%) | 96.96 |
| Portfolio P/B Ratio | 4.98 |
| Portfolio P/E Ratio | 30.62 |
| Fund | Category | |
|---|---|---|
| Average Mkt Cap (Rs Cr) | 56,559 | 56,104 |
| Giant (%) | 15.63 | 15.64 |
| Large (%) | 45.19 | 41.83 |
| Mid (%) | 34.17 | 35.12 |
| Small (%) | 5.01 | 7.40 |
| Tiny (%) | -- | -- |
Please wait...
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 31-Oct-2021
— Alok Ranjan since 06-Aug-2021
Education: Mr. Ranjan has done MBA (Finance), BSc Physics (Honors)
Experience: Prior to joining IDBI Asset Management Limited he was associated with Shriram Asset Management Ltd. as Fund Manager (Equity), Way2wealth Securities Ltd. as Head of Research and Advisory and First Global Ltd. as Vice President- Research.
Funds Managed:
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
| Minimum Investment (₹) | 5,000 |
| Minimum Addl Investment (₹) | 1,000 |
| Minimum SIP Investment (₹) | 500 |
| Minimum No of Cheques | 12 |
| Minimum Withdrawal (₹) | 1,000 |
| Minimum Balance (₹) | 1 |
| Lock-in Period | Not Applicable |
| Exit Load | 1% for redemption within 365 days |
| Fund House: | IDBI Mutual Fund |
| Launch Date: | 28-Feb-2019 |
| Return Since Launch: | 25.17% |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | Very High |
| Type: | Open-ended |
| Assets: | ₹ 75 Cr (As on 31-Oct-2021) |
| Expense: | 2.51% (As on 31-Oct-2021) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | 67.00% |
AMC: IDBI Asset Management Ltd.
Address: 4th Floor, IDBI Tower, WTC Complex, Cuffe Parade, Colaba, Mumbai - 400005
Phone: 022-66442800 / 1800-419-4324
Fax: 022-66442801
Email: [email protected]
Website: http://www.idbimutual.co.in
Registrar & Transfer Agent: KFin Technologies Pvt Ltd.
Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016
Phone: 040-44857874
Email: [email protected]
Website: www.karvymfs.com
You have reserved a spot
Friday, 10-Dec-2021
12:30 PM - 01:00 PM